These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1767088)

  • 1. [Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].
    Astarloa R; Morales B; Peñafiel N; Rábano J; de Yébenes JG
    Rev Clin Esp; 1991 Nov; 189(7):320-4. PubMed ID: 1767088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients.
    Jankovic J; Ford J
    Ann Neurol; 1983 Apr; 13(4):402-11. PubMed ID: 6838174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blepharospasm--oromandibular dystonia (Meige's syndrome) misdiagnosed as secondary hemifacial spasm.
    Gottlieb JS; May M
    Am J Otol; 1984 Jan; 5(3):206-10. PubMed ID: 6720874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia and tremor in spasmodic torticollis.
    Couch JR
    Adv Neurol; 1976; 14():245-58. PubMed ID: 941773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of symptoms in idiopathic torsion dystonia.
    Greene P; Kang UJ; Fahn S
    Mov Disord; 1995 Mar; 10(2):143-52. PubMed ID: 7753056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial dystonia, essential blepharospasm and hemifacial spasm.
    Holds JB; White GL; Thiese SM; Anderson RL
    Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

  • 18. Idiopathic cervical dystonia: clinical characteristics.
    Chan J; Brin MF; Fahn S
    Mov Disord; 1991; 6(2):119-26. PubMed ID: 2057004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and demographic features of Meige's syndrome.
    Sharma AK; Behari M; Ahuja GK
    J Assoc Physicians India; 1996 Sep; 44(9):645-7. PubMed ID: 9251378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.